Kenneth S Rehder

USPTO Granted Patents = 18 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 46(Granted Patents)

Location History:

Durham, NC (US) (2003 - 2023)
Research Triangle Park, NC (US) (2024)

Company Filing History:

Cv Therapeutics, Inc.

patents

5 out of 349

Research Triangle Institute

patents

Years Active: 2003-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11926612 - Heterocyclic apelin receptor (APJ) agonists and uses thereof (2024-03-12),

2. RE49594 - Apelin receptor (APJ) agonists and uses thereof (2023-07-31),

3. 11535630 - Apelin receptor (APJ) agonists and uses thereof (2022-12-27),

4. 10954247 - Apelin receptor (APJ) agonists and uses thereof (2021-03-23),

5. 10100059 - Apelin receptor (APJ) agonists and uses thereof (2018-10-16),

6. 7501446 - Prenylation inhibitors and methods of their synthesis and use (2009-03-10),

7. 7501444 - Prenylation inhibitors and methods of their synthesis and use (2009-03-10),

8. 7452889 - Substituted heterocyclic compounds (2008-11-18),

9. 7262198 - Substituted heterocyclic compounds (2007-08-28),

10. 7166619 - Prenylation inhibitors and methods of their synthesis and use (2007-01-23),

11. 7115610 - Substituted heterocyclic compounds (2006-10-03),

12. 7112596 - Prenylation inhibitors and methods of their synthesis and use (2006-09-26),

13. 7056924 - Substituted heterocyclic compounds (2006-06-06),

14. 7001909 - Substituted heterocyclic compounds (2006-02-21),

15. 6960603 - Prenylation inhibitors and methods of their synthesis and use (2005-11-01),

Title: Inventor Spotlight on Kenneth S. Rehder

Introduction

Kenneth S. Rehder is a notable inventor based in Durham, North Carolina. With an impressive portfolio, he holds a total of 17 patents to his name. His innovation primarily focuses on the field of biochemistry, particularly concerning the apelin receptor and its potential applications in medicine.

Latest Patents

Among his recent contributions to the scientific community are his patents related to apelin receptor (APJ) agonists and their uses. This innovative disclosure is specifically directed towards the development of agonists of the apelin receptor (APJ) and explores the various applications of these agonists in therapeutic settings. These advancements highlight his continuous effort to explore uncharted territories within medicinal chemistry.

Career Highlights

Throughout his career, Kenneth has worked with several renowned companies, including PPD Discovery, Inc. and CV Therapeutics, Inc. His experience in these organizations has significantly contributed to his expertise and the development of cutting-edge technologies within the pharmaceutical industry.

Collaborations

Kenneth has collaborated with several notable individuals during his career, including Prabha N. Ibrahim and Elfatih O. Elzein. These partnerships have played a crucial role in enhancing his research outcomes and leveraging collective knowledge in the field of drug development.

Conclusion

Kenneth S. Rehder’s accomplishments as an inventor highlight his significant contributions to the scientific community, especially in the area of apelin receptor (APJ) research. His ongoing work and collaboration with esteemed colleagues indicate a promising future for innovations in medical therapies that target this critical receptor, ensuring that his inventions will continue to have a lasting impact in the field.

This text is generated by artificial intelligence and may not be accurate.